{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T16:16:34Z","timestamp":1791476194852,"version":"4.3.4"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T00:00:00Z","timestamp":1609200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"DOI":"10.1093\/cid\/ciaa1898","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T20:49:46Z","timestamp":1608842986000},"page":"e274-e275","source":"Crossref","is-referenced-by-count":11,"title":["Doxycycline for ESBL-E Cystitis"],"prefix":"10.1093","volume":"73","author":[{"given":"Tomasz","family":"Jodlowski","sequence":"first","affiliation":[{"name":"Pharmacy Service, VA North Texas Health Care System, Dallas, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles R","family":"Ashby","sequence":"additional","affiliation":[{"name":"St. John\u2019s University College of Pharmacy and Allied Health Professions, Queens, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-7225","authenticated-orcid":false,"given":"Sarath G","family":"Nath","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, University Medical Center, Lubbock, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,29]]},"reference":[{"key":"2021070111153907000_CIT0001","article-title":"Infectious diseases society of America antimicrobial resistant treatment guidance: gram-negative bacterial infections","author":"Tamma","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021070111153907000_CIT0002","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"Agwuh","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"2021070111153907000_CIT0003","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s10096-012-1680-0","article-title":"Oral doxycycline for non-systemic urinary tract infections (UTIs) due to P. aeruginosa and other Gram negative uropathogens","volume":"31","author":"Cunha","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021070111153907000_CIT0004","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10096-016-2577-0","article-title":"An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH","volume":"35","author":"Cunha","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021070111153907000_CIT0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/0897190016642362","article-title":"Successful doxycycline therapy in a patient with Escherichia coli and multidrug-resistant Klebsiella pneumoniae urinary tract infection","volume":"30","author":"White","year":"2017","journal-title":"J Pharm Pract"},{"key":"2021070111153907000_CIT0006","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0022-5347(17)55594-9","article-title":"Comparison of 4 and 10 days of doxycycline treatment for urinary tract infection","volume":"124","author":"Lockey","year":"1980","journal-title":"J Urol"},{"key":"2021070111153907000_CIT0007","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-5347(17)62124-4","article-title":"Doxycycline in the treatment of infections of the urinary tract","volume":"102","author":"Holloway","year":"1969","journal-title":"J Urol"},{"key":"2021070111153907000_CIT0008","doi-asserted-by":"crossref","first-page":"112","DOI":"10.12701\/yujm.2019.00430","article-title":"Does oral doxycycline treatment affect eradication of urine vancomycin-resistant Enterococcus? A tertiary hospital study","volume":"37","author":"Kim","year":"2020","journal-title":"Yeungnam Univ J Med"},{"key":"2021070111153907000_CIT0009","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","article-title":"Doxycycline revisited","volume":"157","author":"Joshi","year":"1997","journal-title":"Arch Intern Med"},{"key":"2021070111153907000_CIT0010","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1177\/1060028014528792","article-title":"Role of doxycycline in Clostridium difficile infection acquisition","volume":"48","author":"Turner","year":"2014","journal-title":"Ann Pharmacother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciaa1898\/36274505\/ciaa1898.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/1\/e274\/38847036\/ciaa1898.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/1\/e274\/38847036\/ciaa1898.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T11:55:07Z","timestamp":1625140507000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/1\/e274\/6054967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,29]]},"references-count":10,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12,29]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciaa1898","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2020,12,29]]}}}